Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. - Wikidata - awgldk - TriplyDB

Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.

Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.

http://www.wikidata.org/entity/Q36861751

about

Update on the treatment of focal segmental glomerulosclerosis in renal transplantation Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential Strategies Mesenchymal stem cells and immunomodulation: current status and future prospects Acute kidney injury: preclinical innovations, challenges, and opportunities for translation Mesenchymal Stromal Cells and Viral Infection Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients Management of fibrosis: the mesenchymal stromal cells breakthrough Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells Mesenchymal stem cell-based therapy in kidney transplantation Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation?Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis.Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.Human adipose-derived mesenchymal stem cells alleviate obliterative bronchiolitis in a murine model via IDO.Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation.Multipotent mesenchymal stromal cells protect against kidney injury Cell-based therapies in kidney disease.Mesenchymal stem cell treatment for chronic renal failure.Mesenchymal stem cells for inducing tolerance in organ transplantation A Distinct Subpopulation of Bone Marrow Mesenchymal Stem Cells, Muse Cells, Directly Commit to the Replacement of Liver Components.Reduction of acute rejection by bone marrow mesenchymal stem cells during rat small bowel transplantation.Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients Comparisons of rabbit bone marrow mesenchymal stem cell isolation and culture methods in vitro.Optimization of multimodal imaging of mesenchymal stem cells using the human sodium iodide symporter for PET and Cerenkov luminescence imaging.Comparisons of mouse mesenchymal stem cells in primary adherent culture of compact bone fragments and whole bone marrow.Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats.iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.Foxp3-modified bone marrow mesenchymal stem cells promotes liver allograft tolerance through the generation of regulatory T cells in rats Autologous Bone Marrow-Derived Mesenchymal Stem Cells Modulate Molecular Markers of Inflammation in Dogs with Cruciate Ligament Rupture.Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.Benefits of mesenchymal stem cells after partial bladder outlet obstruction.Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation.BMI1 inhibits senescence and enhances the immunomodulatory properties of human mesenchymal stem cells via the direct suppression of MKP-1/DUSP1

P2860

Q26751470-DF612486-A036-4AFF-B9DD-2809D76A6B15 Q26752512-175FAA52-6B2B-4C15-87E0-AFBA1B3C0D50 Q26770191-B221113E-8774-4676-8512-EE284B287443 Q26786667-05D49F33-693D-4772-9BA0-C7B76E5E98DA Q26796198-2CA955E4-6060-4525-8259-8445A4E2E8F1 Q26796475-F9AD037A-1F9F-4E7D-ACF4-A569140C658F Q26799916-E786BD73-3EA4-4813-A3BC-0D618F686807 Q26827231-4453B15B-E6EF-42CB-A6A1-2F691556824D Q26866578-23DA4CDB-97B6-4872-9C84-5F9120E576E3 Q27015774-DAB06DB5-0B2F-485A-AA36-DD1BEC505D03 Q28069543-A3606748-4FA0-4E61-B697-5FB288919E71 Q28069791-9FA05D27-2FFD-4404-93E4-58799A5FB5FE Q28069954-2A52B362-4FC9-4F6B-8275-6EFEFBEB368C Q28079089-EC6A3A0B-C508-4DF5-AD68-9FF6F972806D Q33710719-133AC701-1AAE-4C59-A6CD-1EB49ECBCFC2 Q33722487-A098789F-DFE5-4FB7-A578-51A9BBBD0E2E Q33805077-E8665FA4-5C5F-4C97-A544-5A5A4D24E781 Q33816234-57B33DAA-8BE5-4F63-ABDE-F33D0398E1C2 Q33828834-0A8D97EC-54F9-4BF5-828A-5BD554A3AA8D Q33873259-023C440D-C4A4-470B-B356-5F89683B57BD Q33900483-E6DFDCAE-8087-4022-968D-4EF701D9E94A Q34391029-EC9B5490-6265-4800-B391-092A7BF43C02 Q34504983-4683FD72-DD6C-4EA9-BA1A-3FC1CCAAC408 Q34702762-43F46006-C2E6-4D85-B725-9191E7B63F73 Q34753440-CD0804B7-D7A0-4AB3-9446-96E210240623 Q35099685-717BF0C1-4BDD-42FA-BE28-BB76000E4C44 Q35152909-B9373094-C4A3-4BBC-A1B4-FA5F51C56AAA Q35188018-C4AAFD21-7397-4E71-A99A-72D3B1FF8C52 Q35205677-45259F12-9D61-4308-BF6D-9F3FA00EDBAE Q35344810-5214041F-B5E0-48D9-B419-905FDA89F629 Q35752262-7DDD43E6-6EF1-44A1-852B-BC54963FA1A3 Q35866047-12D29FE0-EC4D-45C0-9D4B-0AA344832586 Q35986119-BEBC942B-1173-4E07-A1BC-8B186FA8E583 Q36116711-1615E42B-6950-4B04-B3EC-02191EDA06D4 Q36246918-7307D13A-5520-4961-8A3F-123A136F7C50 Q36510163-9EE5E09A-AA75-459E-945B-63A272417A44 Q37022116-267C4A64-8165-4BD0-B234-26CA03CC960B Q37079961-0921A6F7-78E7-48A1-9F20-1594E92AFD93 Q37243068-C0A1E6F8-8124-446E-A162-7F88EE4A34F0 Q37274966-3EFB5385-4A22-4AE2-BEE5-FC0BCE140E54

P2860

Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.

http://www.wikidata.org/entity/Q36861751

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Autologous bone marrow-derived ...... n: results of a phase I study.

@en

type

label

Autologous bone marrow-derived ...... n: results of a phase I study.

@en

prefLabel

Autologous bone marrow-derived ...... n: results of a phase I study.

@en

P1433

Q36861751-679D901E-B4B9-4980-BB2F-47E001D7F69B

P1476

Q36861751-29D65FA0-2A72-418D-9DDC-19677BAB5DD8

P2093

Q36861751-2BB9A45B-9A97-445B-98D0-28ABA9BE7AB5

Q36861751-2EDB76AD-DB96-4C0F-A638-F11474DC90EB

Q36861751-3BC2A902-62BD-46B9-99B8-8FABDB137C7D

Q36861751-4231DA9F-FB26-4F64-B907-588416F7C371

Q36861751-5199D99A-93F6-43AE-95E0-B0417DB5B04A

Q36861751-54B0D49E-3F3B-4F61-87B7-CED968BA0EDF

Q36861751-6CE5BD7C-5E2B-4A93-8645-4FFBC1B14856

Q36861751-A39C1031-6880-4534-8E99-71951E71B755

Q36861751-AABB53F7-AAEB-4A69-96BF-7E3A03B97153

Q36861751-DEB36A39-86FA-448B-8C1F-09868D91C3AE

P2860

Q36861751-199C6BEA-79BA-4704-958E-4375A58193C6

Q36861751-2F091E0F-5197-4BC3-AFB5-B90F6BAB02FB

Q36861751-5C73E13B-E10B-4CAA-88A6-4B5CD580757C

Q36861751-68DE8AC3-7BE6-422C-AA6E-0D9D6692D093

Q36861751-78AE9503-7C6E-45FB-AE42-4FAC40C38C7E

Q36861751-925591F5-B1B6-4D7C-A874-16683CD8E738

Q36861751-975F2BA6-B4CB-4CE9-8ED0-C23D34A3ADA5

Q36861751-99A11454-15B6-4377-B1F5-5295E27036BC

Q36861751-B91A8D2F-3CFD-4C53-9892-085A24367ADE

Q36861751-D0492D48-6D16-45D3-AFDC-B84114807700

P304

Q36861751-90B510E7-CB87-4AA4-9E70-2026C550928A

P31

Q36861751-670E132E-2789-4AA4-9BFA-D3753E08214C

P356

Q36861751-13252E86-6C9E-4A95-AAD5-F10221AABC8F

P433

Q36861751-801512B7-8772-46C6-9BE2-0C865475675D

P478

Q36861751-629F3A88-3797-4E58-86F6-7B33A76EEA6D

P50

Q36861751-87199302-CF7B-40F6-B9DE-EB3149129F11

P577

Q36861751-4C9C9EBC-8A39-453D-A0CA-DAA15F21938C

P5875

Q36861751-0FDCF2D7-D436-4F69-B412-11363230EAF9

P698

Q36861751-E1570014-8518-4AD6-8944-011B0260D2C8

P932

Q36861751-00FCCA22-218A-4746-B2F8-C99E795792A2

P356

P1433

Stem Cells Translational Medicine

P1476

Autologous bone marrow-derived ...... n: results of a phase I study.

@en

P2093

Alexander F Schaapherder

http://www.w3.org/2001/XMLSchema#string

Cees van Kooten

http://www.w3.org/2001/XMLSchema#string

Dave L Roelen

http://www.w3.org/2001/XMLSchema#string

Dorottya K de Vries

http://www.w3.org/2001/XMLSchema#string

Frans H J Claas

http://www.w3.org/2001/XMLSchema#string

Helene Roelofs

http://www.w3.org/2001/XMLSchema#string

Ingeborg M Bajema

http://www.w3.org/2001/XMLSchema#string

Johan W de Fijter

http://www.w3.org/2001/XMLSchema#string

Marlies E J Reinders

http://www.w3.org/2001/XMLSchema#string

Paula P M C van Miert

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal stromal cells: current understanding and clinical status.

Strategies to improve long-term outcomes after renal transplantation.

Concise review: hitting the right spot with mesenchymal stromal cells.

Mesenchymal stromal cells: facilitators of successful transplantation?

Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.

Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice.

Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.

Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies.

P304

107-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5966/SCTM.2012-0114

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235371696

http://www.w3.org/2001/XMLSchema#string

P698

23349326

http://www.w3.org/2001/XMLSchema#string

P932

3659754

http://www.w3.org/2001/XMLSchema#string